The clinical significance of immunosuppression in ovarian cancer microenvironments
2021/41/N/NZ6/01727
Keywords
Descriptors
- NZ6_002: Immunologia kliniczna
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Uniwersytet Medyczny w Lublinie
Voivodeship: lubelskie
Principal investigator (from the host institution)
dr Anna Maria Pawłowska-Łachut
Number of co-investigators in the project: 3
Call
PRELUDIUM 20 – announced on 2021-03-15
- Amount awarded
- 209 870 PLN
- Project start date
- 2022-02-01
- Project end date
- 2027-01-31
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients
- Authors:
- Pawłowska Anna, Wiktoria Skiba, Dorota Suszczyk, Weronika Kuryło, Joanna Jakubowicz-Gil, Roman Paduch, Iwona Wertel
- Academic press:
- Cancers (year: 2022, volume: 14, pages: 5757), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/cancers14235757 – link to the publication
-
Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors
- Authors:
- Anna Pawłowska , Anna Rekowska, Weronika Kuryło, Anna Pańczyszyn, Jan Kotarski, Iwona Wertel
- Academic press:
- International Journal of Molecular Sciences (year: 2023, volume: 24, pages: 10859), Publisher: Multidisciplinary Digital Publishing Institute
- Status:
- Published
- DOI:
- 10.3390/ijms241310859 – link to the publication